BIO KEY INTERNATIONAL INC
BKYI$7M
Micro CapNASDAQServices-Prepackaged Software🇺🇸North AmericaHOLMDEL
Drugs in Pipeline
4
Phase 3 Programs
3
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
BKYI News
Catalyst Timeline
0 upcoming, 0 past
No catalysts found.
Drug Pipeline
N1539
Pain, Postoperative
Tinlarebant
Stargardt Disease 1
Roxadustat
CKD Anemia
PRX302
Benign Prostatic Hyperplasia
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
N1539 | Phase 3 | Pain, Postoperative | - | - |
Tinlarebant | Phase 3 | Stargardt Disease 1 | - | - |
Roxadustat | Phase 3 | CKD Anemia | - | - |
PRX302 | Phase 2 | Benign Prostatic Hyperplasia | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply